129 related articles for article (PubMed ID: 12868558)
1. Bilateral hearing loss during vincristine therapy: a case report.
Kalcioglu MT; Kuku I; Kaya E; Oncel S; Aydogdu I
J Chemother; 2003 Jun; 15(3):290-2. PubMed ID: 12868558
[TBL] [Abstract][Full Text] [Related]
2. Bilateral transient hearing loss associated with vincristine therapy: case report.
Aydogdu I; Ozturan O; Kuku I; Kaya E; Sevinc A; Yildiz R
J Chemother; 2000 Dec; 12(6):530-2. PubMed ID: 11154039
[TBL] [Abstract][Full Text] [Related]
3. Sensorineural hearing loss associated with vincristine treatment.
Lugassy G; Shapira A
Blut; 1990 Nov; 61(5):320-1. PubMed ID: 2271781
[TBL] [Abstract][Full Text] [Related]
4. Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening.
Verstappen CC; Koeppen S; Heimans JJ; Huijgens PC; Scheulen ME; Strumberg D; Kiburg B; Postma TJ
Neurology; 2005 Mar; 64(6):1076-7. PubMed ID: 15781834
[TBL] [Abstract][Full Text] [Related]
5. Reversible vincristine-related flaccid paralysis in a child with acute lymphoblastic leukemia.
Fioredda F; Micalizzi C; Lanciotti M; Dufour C; Lamba LD; Fiocchi I
Med Pediatr Oncol; 2002 Aug; 39(2):141-2. PubMed ID: 12116067
[No Abstract] [Full Text] [Related]
6. [Angioimmunoblastic T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy for follicular lymphoma].
Miyazaki K; Masuya M; Yamaguchi M; Isaka S; Nakase K; Kobayashi T; Nakamura S; Shiku H
Rinsho Ketsueki; 2005 Sep; 46(9):1065-70. PubMed ID: 16440766
[TBL] [Abstract][Full Text] [Related]
7. Low-dose vincristine-associated bilateral vocal cord paralysis.
Ryan SP; DelPrete SA; Weinstein PW; Erichson RB; Bar MH; Lo KM; Cohen NS; Tepler I
Conn Med; 1999 Oct; 63(10):583-4. PubMed ID: 10578547
[TBL] [Abstract][Full Text] [Related]
8. Fatal consequences of a simple mistake: how can a patient be saved from inadvertent intrathecal vincristine?
Reddy GK; Brown B; Nanda A
Clin Neurol Neurosurg; 2011 Jan; 113(1):68-71. PubMed ID: 20846784
[No Abstract] [Full Text] [Related]
9. Drug administration. A fatal error of judgement.
Gulland A
Nurs Times; 2001 Feb 1-7; 97(5):11. PubMed ID: 11954166
[No Abstract] [Full Text] [Related]
10. Role of ciclosporin in steroid-responsive sudden sensorineural hearing loss.
McClelland L; Powell RJ; Birchall J
Acta Otolaryngol; 2005 Dec; 125(12):1356-60. PubMed ID: 16303687
[TBL] [Abstract][Full Text] [Related]
11. Zygomycosis in a 13 year old girl with T-NHL.
Kollmar N; Lakomek M; Kühnle I
Klin Padiatr; 2009; 221(6):382-3. PubMed ID: 19890792
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience.
Escalón MP; Liu NS; Yang Y; Hess M; Walker PL; Smith TL; Dang NH
Cancer; 2005 May; 103(10):2091-8. PubMed ID: 15816054
[TBL] [Abstract][Full Text] [Related]
13. A prospective cohort study of the effect of vincristine on audition.
Lugassy G; Shapira A
Anticancer Drugs; 1996 Jul; 7(5):525-6. PubMed ID: 8862718
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal vincristine: 3 fatal cases and a review of the literature.
Hennipman B; de Vries E; Bökkerink JP; Ball LM; Veerman AJ
J Pediatr Hematol Oncol; 2009 Nov; 31(11):816-9. PubMed ID: 19801949
[TBL] [Abstract][Full Text] [Related]
15. Unilateral Vocal Cord Motion Impairment After 1 Dose of Vincristine: Case Report and Literature Review.
Aaron H; Azadarmaki R; Lango MN
Am J Ther; 2016; 23(2):e621-3. PubMed ID: 25738569
[TBL] [Abstract][Full Text] [Related]
16. Fatal myeloencephalopathy due to accidental intrathecal vincristin administration: a report of two cases.
Dettmeyer R; Driever F; Becker A; Wiestler OD; Madea B
Forensic Sci Int; 2001 Oct; 122(1):60-4. PubMed ID: 11587867
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of vincristine toxicity by itraconazole in children with lymphoid malignancies.
Kamaluddin M; McNally P; Breatnach F; O'Marcaigh A; Webb D; O'Dell E; Scanlon P; Butler K; O'Meara A
Acta Paediatr; 2001 Oct; 90(10):1204-7. PubMed ID: 11697438
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal vincristine: an analysis of reasons for recurrent fatal chemotherapeutic error with recommendations for prevention.
Fernandez CV; Esau R; Hamilton D; Fitzsimmons B; Pritchard S
J Pediatr Hematol Oncol; 1998; 20(6):587-90. PubMed ID: 9856687
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia.
Thomas DA; Sarris AH; Cortes J; Faderl S; O'Brien S; Giles FJ; Garcia-Manero G; Rodriguez MA; Cabanillas F; Kantarjian H
Cancer; 2006 Jan; 106(1):120-7. PubMed ID: 16331634
[TBL] [Abstract][Full Text] [Related]
20. Secondary acute myeloid leukemia following treatment with VP16-containing regimens for non-Hodgkin's lymphoma.
Orlandi E; Lazzarino M; Bernasconi P; Astori C; Bernasconi C
Haematologica; 1998 Aug; 83(8):758-9. PubMed ID: 9793267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
